368 related articles for article (PubMed ID: 19243705)
1. A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM; Meyer-Massetti C; Kayser SR
Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
[TBL] [Abstract][Full Text] [Related]
2. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
[TBL] [Abstract][Full Text] [Related]
3. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA; Crean S; Reynolds MW
Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
[TBL] [Abstract][Full Text] [Related]
4. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.
Chapman WC; Singla N; Genyk Y; McNeil JW; Renkens KL; Reynolds TC; Murphy A; Weaver FA
J Am Coll Surg; 2007 Aug; 205(2):256-65. PubMed ID: 17660072
[TBL] [Abstract][Full Text] [Related]
5. Topical thrombins: benefits and risks.
Lomax C; Traub O
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in topical thrombins.
Kessler CM; Ortel TL
Thromb Haemost; 2009 Jul; 102(1):15-24. PubMed ID: 19572062
[TBL] [Abstract][Full Text] [Related]
7. Topical recombinant human thrombin in surgical hemostasis.
Bowman LJ; Anderson CD; Chapman WC
Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
[TBL] [Abstract][Full Text] [Related]
8. Thrombin products: economic impact of immune-mediated coagulopathies and practical formulary considerations.
Voils SA
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):18S-22S. PubMed ID: 19558281
[TBL] [Abstract][Full Text] [Related]
9. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery.
Doria C; Fischer CP; Wood CG; Li PM; Marra S; Hart J
Curr Med Res Opin; 2008 Mar; 24(3):785-94. PubMed ID: 18241525
[TBL] [Abstract][Full Text] [Related]
10. Achieving hemostasis in the surgical field.
Boucher BA; Traub O
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):2S-7S. PubMed ID: 19558278
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human thrombin: in surgical hemostasis.
Croxtall JD; Scott LJ
BioDrugs; 2009; 23(5):333-8. PubMed ID: 19754221
[TBL] [Abstract][Full Text] [Related]
12. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of recombinant human thrombin: a pooled analysis of results from 10 clinical trials.
Singla NK; Foster KN; Alexander WA; Pribble JP
Pharmacotherapy; 2012 Nov; 32(11):998-1005. PubMed ID: 23108631
[TBL] [Abstract][Full Text] [Related]
14. Topical use of recombinant human thrombin for operative hemostasis.
Anderson CD; Bowman LJ; Chapman WC
Expert Opin Biol Ther; 2009 Jan; 9(1):133-7. PubMed ID: 19063699
[TBL] [Abstract][Full Text] [Related]
15. Bovine thrombin: history, use, and risk in the surgical patient.
Diesen DL; Lawson JH
Vascular; 2008; 16 Suppl 1():S29-36. PubMed ID: 18544303
[TBL] [Abstract][Full Text] [Related]
16. Safety of topical thrombins: the ongoing debate.
Lomax C
Patient Saf Surg; 2009 Sep; 3(1):21. PubMed ID: 19732447
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA
J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated coagulopathy: a case report.
Naoum JJ
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):13S-7S. PubMed ID: 19558280
[TBL] [Abstract][Full Text] [Related]
19. The use fibrinogen/thrombin-coated equine collagen patch in children requiring reoperations for congenital heart disease. A single center clinical experience.
Vida VL; De Franceschi M; Barzon E; Padalino MA; Scattolin F; Stellin G
J Cardiovasc Surg (Torino); 2014 Jun; 55(3):401-6. PubMed ID: 24755705
[TBL] [Abstract][Full Text] [Related]
20. Prospective, Randomized, Phase II, Non-Inferiority Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as Adjunct to Hemostasis During Vascular, Hepatic, Soft Tissue, and Spinal Open Surgery.
Minkowitz H; Navarro-Puerto J; Lakshman S; Singla S; Cousar C; Kim R; Villavicencio A; Kirksey L; Ayguasanosa J;
J Am Coll Surg; 2019 Nov; 229(5):497-507.e1. PubMed ID: 31376435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
